R1 RCM Inc  

(Public, NASDAQ:RCM)   Watch this stock  
Find more results for tse:rcm
+0.17 (6.25%)
After Hours: 2.89 0.00 (0.00%)
Mar 23, 4:00PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.64 - 2.90
52 week 1.47 - 2.99
Open 2.70
Vol / Avg. 0.00/282,161.00
Mkt cap 324.09M
P/E 4.49
Div/yield     -
EPS 0.64
Shares 105.96M
Beta -0.60
Inst. own 35%

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 12.36% 29.88%
Operating margin 25.91% 50.27%
EBITD margin - 52.79%
Return on average assets 12.17% 40.46%
Return on average equity - -
Employees 3,152 -
CDP Score - -


401 N Michigan Ave Ste 2700
CHICAGO, IL 60611-4217
United States - Map
+1-312-3247820 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


R1 RCM Inc., formerly Accretive Health, Inc., is a provider of revenue cycle services to healthcare providers. The Company offers revenue cycle management (RCM) service and physician advisory services (PAS). The Company operates through the business of providing end-to-end management services of revenue cycle operations for the United States-based hospitals and other medical providers segment. It also offers modular services, allowing clients to engage in specific components of its RCM service offering. Its customers are single or multi-hospital healthcare systems, including faith-based healthcare systems, community healthcare systems, academic medical centers and their affiliated ambulatory clinics, and physician practice groups. The Company's population health solutions (PHS) services are designed to enable healthcare providers to manage the health of a defined patient population by identifying various individuals. The Company utilizes the R1 Performance Stack.

Officers and directors

Steven J. Shulman Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Joseph Gerard Flanagan President, Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
Christopher Simon Ricaurte Chief Financial Officer, Treasurer
Age: 56
Bio & Compensation  - Reuters
Douglas A. Berkson Senior Vice President
Bio & Compensation  - Reuters
Michael C. Feiner Director
Age: 74
Bio & Compensation  - Reuters
John Bell Henneman III Director
Age: 54
Bio & Compensation  - Reuters
Joseph R. Impicciche Director
Age: 58
Bio & Compensation  - Reuters
Neal Moszkowski Director
Age: 50
Bio & Compensation  - Reuters
Ian R. Sacks Director
Age: 45
Bio & Compensation  - Reuters